Root Financial Partners’s Cocrystal Pharma COCP Stock Holding History

Root Financial Partners’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7	Closed	-$7	–	3489
2025 Q4	$7	Buy	+7	New	+$7	﹤0.01%	2423

Other funds holding COCP

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T3 Companies New York $76.8M AUM

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Root Financial Partners's COCP Position: Q1 2026 in Review

Root Financial Partners sold out of Cocrystal Pharma (COCP) in Q1 2026, closing a stake of 7 shares — an estimated $7 sold.

Root Financial Partners first reported a position in COCP in Q4 2025 and held it in 1 quarter. The position peaked at $7 in Q4 2025. 26 funds tracked by Wall St. Rank hold COCP as of Q1 2026.

Root Financial Partners reported no remaining Cocrystal Pharma position as of Q1 2026 after selling out during the quarter.
Root Financial Partners sold 7 Cocrystal Pharma shares in Q1 2026, an estimated $7.
Root Financial Partners first reported a position in Cocrystal Pharma in Q4 2025 and held it in 1 quarter.
Root Financial Partners's Cocrystal Pharma position peaked at $7 in Q4 2025.
26 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.